More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

Microscopy Images of its Synthetic Antibiotic in Action Dest

Feb 23, 2017 at 11:22 PM EST · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · Feb 23, 2017 at 11:22 PM EST · 3 pages · English

On 6ix: 6ix.com/news/microscopy-images-of-its-synthetic-antibiotic-in-action-dest

Recce Pharmaceuticals Ltd. on 6ix

Earlier from Recce Pharmaceuticals

  • Recce to suspend anti-cancer programFeb 22, 2017
  • Operational Update and Quarterly Cash FlowJan 30, 2017
  • Lead compound reduces illness in mice infected by E.coliJan 17, 2017
  • Encouraging anti-viral activity for lead compound RECCE 327Dec 20, 2016
  • Pre-clinical toxicology and efficacy testingNov 2, 2016

Later from Recce Pharmaceuticals

  • Appendix 4D and Interim Financial StatementsFeb 28, 2017
  • Data from large animal study shows RECCE 327 well toleratedMar 26, 2017
  • Operational UpdateApr 9, 2017
  • Recce moves closer to clinical study applicationMay 19, 2017
  • Recce secures up to A$6.05 million investment agreement withJun 16, 2017
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer